New Zealand-based AI healthcare company Toku Eyes has launched its retina-based AI health screening platform in the United States.
Its latest offering, ORAiCLE, can assess and calculate a person’s cardiovascular risk through a retinal scan. Still a patent pending, AI technology uses an image behind the user’s eye taken from a retinal camera. The platform changes blood vessels, capillaries, arteries and other indicators in minutes to predict a user’s risk of stroke or heart attack over the next five years.
Toku Eyes has already established a local partnership with EyeCheq, which is building a nationwide network of self-service retinal image kiosks and a provider of image management platforms for Unified Imaging, an eye care clinic.
The company aims to bring its platform to more than 1,500 locations across the United States by 2025, subject to regulatory clearance.
Why it matters
More than 80% of heart attacks are considered preventable if detected early in high-risk cases. However, according to Toku Eyes, traditional methods of determining high-risk patients have become “inaccurate, costly and aggressive” where 40% of diabetic and prediabetic individuals are unable to access critical screening.
The company has come up with the ORAiCLE platform which is known to be more affordable and easily accessible in places like pharmacy and self-service retinal photo kiosks. Toku Eyes further claims that its technology can work properly with relatively low quality images Similar technology to Google.
“It is often unknown that the cardiovascular system is capable of taking pictures through the eyes,” it says.
John Marshall, who invented excimer technology to correct refractive errors in the eye, said that “[u]Sing the eye as a diagnostic tool for external conditions of the eye so now the eye specialist can start talking to the cardiovascular surgeon “.
“It simply came to our notice then.
The Toku Eyes’ AI platform has been used as part of diabetic screening services in public and private health facilities in New Zealand. The technology has also been brought live to 20 clinics in India, where the company plans to roll out 50 more by the end of the year.
In other news, a research project in Thailand has used an in-depth learning algorithm to accurately detect diabetic retinopathy in diabetic patients. The The Google-backed study used the algorithm to photograph more than 7,500 patients whose readings matched those of retinal specialists.
“Looking inside, we get a deeper insight into what’s happening inside the whole body to better assess each person’s risk factors and identify high-risk individuals before their condition worsens. Our goal is to make health screening easier. And accessible to the entire population.” Easy so that we can get ahead of the underlying health risks and improve patient outcomes, “said Ehsan Vaghefi, CEO and co-founder of Toku Eyes.